RIZATRIPTAN BENZOATE (MAXALT) Nursing Considerations

What is the generic name?

RIZATRIPTAN BENZOATE

What is the Trade Name for RIZATRIPTAN BENZOATE?

MAXALT

What are the Indications for RIZATRIPTAN BENZOATE?

• 1 INDICATIONS AND USAGE MAXALT ¬Æ and MAXALT-MLT ¬Æ are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use MAXALT should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with MAXALT, the diagnosis of migraine should be reconsidered before MAXALT is administered to treat any subsequent attacks. MAXALT is not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ] . MAXALT is not indicated for the prevention of migraine attacks. Safety and effectiveness of MAXALT have not been established for cluster headache. MAXALT is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age ( 1 ) Limitations of Use : Use only after clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 )

References: https://open.fda.gov/